PURPOSE
An alternative approach to anal Bowen’s disease was investigated. The use of topical 5 percent 5-fluorouracil for large lesions and surgical excision of small lesions were evaluated.
METHODS
A prospective study was undertaken for anal Bowen’s disease in 11 patients over a six-year period. Before therapy all patients underwent anal mapping biopsy and colonoscopy. For one-half circumferential disease or greater, patients underwent topical 5 percent 5-fluorouacil therapy for 16 weeks. For smaller involvement, wide surgical excision was performed. All patients underwent anal mapping biopsy one year after completion of therapy.
RESULTS
Of 11 patients, 8 (5 male) received 16 weeks of topical 5 percent 5-fluorouacil therapy. Three patients (3 female) underwent surgical excision for localized disease. All but one patient, who was HIV positive, were free of Bowen’s disease one year after completion of therapy. One patient underwent total excision of a residual microinvasive squamous carcinoma after circumferential Bowen’s dis-ease had resolved. One patient received eight additional weeks of topical 5-fluorouacil therapy for incomplete resolution. All patients were followed yearly, with a mean follow-up of 39 months and a range of 12 to 74 months. There have been no recurrences. There were no long-term side effects or morbidity from topical 5-fluorouacil or local excision. All colonoscopies were normal.
CONCLUSION
Topical 5 percent 5-fluorouacil therapy is a safe and effective method to treat anal Bowen’s disease. Wide local excision is appropriate for smaller, isolated areas of disease. Anal Bowen’s disease was not associated with colonic or other neoplasms.
Similar content being viewed by others
REFERENCES
JT Bowen (1912) ArticleTitlePrecancerous dermatosis: a study of two cases of chronic a-typical epithelial proliferation J. Cutan. Dis 30 241–55
PM Vickers RJ Jackmun JR McDonald (1939) ArticleTitleAnal carcinoma in situ: report of three cases South Surgeon 8 503–7
RA Schwartz HL Stoll (1993) Epithelial precancerous lesions McGraw-Hill New York 804–21
KT Pedersen L Raunborg F Reymann (1988) ArticleTitleMorbus Bowen Acta Derm Venereal (Stockh.) 68 236–9
JH Graham EB Hellwig (1966) Cutaneous premalignant lesions. Advances in biology of the skin Pergamon Press New York 422–30
L Grodsky (1957) ArticleTitleIntraepidermal cancer of the anus evolution in invasive growth Calif Med 87 89–94
RK Cleary JD Schaldenbrand JJ Fowler JM Schuler RM Lampman (2000) ArticleTitleTreatment options for perianal Bowen’s disease: survey of American Society of Colon Rectal Surgeon Members Am Surg 63 686–8
JM Sarmiento BG Wolff LJ Burgart FA Frizelle DM Ilstrup (1997) ArticleTitlePerianal Bowen’s disease, associated tumors, human papillomavirus, surgery and other controversies Dis Colon Rectum 40 912–18 Occurrence Handle1:STN:280:ByiH3MzjvFY%3D Occurrence Handle9269807
P Marchesa VN Fazio S Oliart JR Goldblum ID Lavery (1997) ArticleTitlePerianal Bowen’s disease: a clinicopathologic study of 47 patients Dis Colon Rectum 40 1286–93 Occurrence Handle1:STN:280:DyaK1c%2FjsVSgtg%3D%3D Occurrence Handle9369101
HM Strum (1979) ArticleTitleBowen’s disease and 5-fluorouracil J Am Acad Dermatol 1 513–22 Occurrence Handle528700
DE Beck VW Fazio DG Jagelman IC Lavery (1988) ArticleTitlePerianal Bowen’s disease Dis Colon Rectum 31 419–22 Occurrence Handle1:STN:280:BieB2c3js1Q%3D Occurrence Handle3288448
SM Sentovich PM Falk MA Christensen AG Thorson GJ Blatchford RM Pitsch (1996) ArticleTitleOperative results of house advancement anoplasty Br J Surg 83 1242–4 Occurrence Handle1:STN:280:ByiC3crktlw%3D Occurrence Handle8983616
E Klein F Helm H Milgrom et al. (1962) ArticleTitleTumors of the skin II Keratoacanthoma: local effect of 5-FU Skin (Los Angeles) 1 153–6 Occurrence Handle1:STN:280:CC2D2MfhsVI%3D
ML Welch WJ Grabski ML McCollough et al. (1997) ArticleTitle5-FU ionophoretic therapy for Bowen’s disease J Am Acad Dermatol 36 856–8
C Del Miquel Sanchez CO Olmos BA Saez et al. (1994) ArticleTitleBowen’s disease. A report of 9 cases Aten Primaria 13 199–202 Occurrence Handle8180308
DK Goette TE Carson (1976) ArticleTitleErythroplasia of Queyrat: treatment with topical 5 fluorouracil Cancer 38 1498–502 Occurrence Handle1:STN:280:CSiD2cnnvFE%3D Occurrence Handle991073
BM Tolia VL Castro IM Mouded et al. (1976) ArticleTitleBowen’s disease of the shaft of penis. Successful treatment with 5-FU Urology 7 617–9 Occurrence Handle1:STN:280:CSmB38rnvVI%3D Occurrence Handle936382
BL Limmer (1975) ArticleTitleBowen’s Disease treatment with topical 5-fluorouracil Cutis 16 660–3
CJ Dillahu GJ Jansen WM Honeycutt GA Holt (1965) ArticleTitleFurther studies with topical 5-fluorouracil Arch Dermatol 92 410–7 Occurrence Handle5835333
R Ramos H Salinas L Tucker (1983) ArticleTitleConservative approach to the treatment of Bowen’s disease of the anus Dis Colon Rectum 26 712–5 Occurrence Handle1:STN:280:BiuD38fgvFw%3D Occurrence Handle6628143
SS Cohen JG Flaks HD Barner et al. (1958) ArticleTitleThe mode of action of 5-fluorouracil and its derivatives Proc Natl Acad Sci USA 44 1004–12 Occurrence Handle1:CAS:528:DyaG1MXktVGjsQ%3D%3D
O Skold (1958) ArticleTitleEnzymatic ribosidation and ribotidation of 5-FU by extracts of ehrlich-ascites tumor Biochm Biopsys Acta 29 651 Occurrence Handle1:CAS:528:DyaG1MXht1SntQ%3D%3D
JH Raaf SE Krown CM Pinsky et al. (1976) ArticleTitleTreatment of Bowen’s disease with topical dinitrochlorobenzene and topical 5-fluorouracil Cancer 37 1633–42 Occurrence Handle1:STN:280:CSmC283pt1Y%3D Occurrence Handle1260680
GJ Jansen C Dillaha M Honeycutt (1967) ArticleTitleSelective cytotoxic effect of topical 5-FU South Med J 60 185–8 Occurrence Handle1:STN:280:CCiD1czjsVM%3D Occurrence Handle6016410
RF Ryan MW Marks (1988) ArticleTitle5-FU in treatment of carcinoma of nasal floor and alae Ann Plast Surg 20 48–54 Occurrence Handle1:STN:280:BieC3s3ktFU%3D Occurrence Handle3341716
BB Mason RF Scott JJ Headington (1989) ArticleTitleManagement of oral squamous cell carcinoma in situ with topical 5-FU and laser surgery Oral Surg 68 44–8 Occurrence Handle2666897
RL Orson MA Everett (1975) ArticleTitleEpidermal apoptosis; cell deletion by phagocytosis J Cutan Pathol 2 53–7 Occurrence Handle1228210
PWA Mansell MS Litwin (1975) ArticleTitleDelayed hypersensitivity to 5-FU following topical chemotherapy of cutaneous cancers Cancer Res 35 1288–94 Occurrence Handle1:STN:280:CSqC38bhvVE%3D Occurrence Handle1120313
E Klein (1969) ArticleTitleHypersensitivity reactions to tumor sites Cancer Res 29 2351–62 Occurrence Handle1:STN:280:CS%2BB1M7hsl0%3D Occurrence Handle5387265
E Klein GA Holtermann (1974) ArticleTitleResponses of neoplasms to local immunotherapy Am J Clin Pathol 62 281–9 Occurrence Handle1:STN:280:CSuB2sfgtlY%3D Occurrence Handle4602090
I Orengo T Rosen CK Guill (2002) ArticleTitleTreatment of squamous cell carcinoma in situ of penis with 5% imiquimod cream: A case report J Am Acad Dermatol 47 5225–8
JC Zampogna FP Flowers WI Roth et al. (2002) ArticleTitleTreatment of primary limited cutaneous extramammary Paget’s disease with topical imiquimod monotherapy: two case reports J Am Acad Dermatol 47 5229–35
GJ Chang JM Berry V Jay JM Palefsky ML Welton (2002) ArticleTitleSurgical treatment of high grade anal squamous intraepithelial lesions: A prospective study Dis Colon Rectum 45 453–8 Occurrence Handle12006924
JJ Goedert TR Cote P Virgo et al. (1998) ArticleTitleSpectrum of AIDS associated malignant disorders Lancet 352 1833–9
JM Palefsky EA Holly ML Ralston V Jay JM Berry TM Darragh (1998) ArticleTitleHigh incidence of anal high grade squamous intra-epithelial lesions among HIV positive and HIV negative homosexual and bisexual men AIDS 12 495–503 Occurrence Handle10.1097/00002030-199805000-00011 Occurrence Handle1:STN:280:DyaK1c3gt1Cmsg%3D%3D Occurrence Handle9543448
VH Reynolds JJ Madden JP Franklin et al. (1984) ArticleTitlePreservation of anal function after total excision of the anal canal mucosa for Bowen’s Disease Ann Surg 199 563–8 Occurrence Handle1:STN:280:BiuB3c3gtFw%3D Occurrence Handle6372711
CG Chute T Chuang EJ Bergstrahl et al. (1991) ArticleTitleThe subsequent risk of internal cancer with Bowen’s disease: a population based study JAMA 226 816–9
H Arbesman DF Ramsohoff (1987) ArticleTitleIs Bowen’s disease a predictor for the development of internal malignancy? A methodological critique of the literature JAMA 257 516–8 Occurrence Handle1:STN:280:BiiD1cjgtlc%3D Occurrence Handle3795434
Author information
Authors and Affiliations
About this article
Cite this article
Graham, B., Jetmore, A., Foote, J. et al. Topical 5-Fluorouracil in the Management of Extensive Anal Bowen’s Disease: A Preferred Approach. Dis Colon Rectum 48, 444–450 (2005). https://doi.org/10.1007/s10350-004-0901-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-0901-8